#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection Chronic lymphocytic leukaemia Haemophilia A with anti factor VIII Alexander disease Lymphangiosarcoma Thromboangiitis obliterans PIK3CA-activated mutation Immunodeficiency common variable Acute myeloid leukaemia Anal fistula Duchenne muscular dystrophy gene carrier Cytokine release syndrome Orthostatic hypotension Pericarditis Acute graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Diagnostics Nephrotic syndrome – Life with Disease Pulmonary fibrosis – Life with Disease Tuberous sclerosis complex Nodal marginal zone B-cell lymphoma Von Willebrand’s disease Anaplastic thyroid cancer Mantle cell lymphoma stage IV – Diagnostics Basal cell naevus syndrome – Life with Disease Encephalitis autoimmune – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hct116-B Itepekimab Carbamazepine (Ph. Eur.) Foscarnet 20-HYDROXYECDYSONE Cerebrolysin Concentrate Nicotinamide Bp Tuvusertib Enzalutamide Quercus Robur Pollen Extract A3907 Dactylis Glomerata HYDROGEN Cedazuridine Cldn6 Rna-Lpx Fluconazole HUMAN PLASMA Everolimus Human Serum Albumin EGANELISIB More therapies…

    Learn about Your Condition

    Juvenile spondyloarthritis Thrombocytopenia Fibrosarcoma metastatic Frontotemporal dementia Laparoscopic surgery Lymphocytic leukaemia Atrial flutter Malignant peritoneal neoplasm Hyperphagia Colon cancer Pancreaticoduodenectomy Insomnia Endometrial cancer stage II Eye disorder Supranuclear palsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Subarachnoid haemorrhage

  • Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

    Recruiting

    2 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • 1,4-Diamino-2,3-Dicyano-1,4-Bis(O-Aminophenylmercapto)Butadiene Hemiethanolate
    Denmark

  • Study on the Effects of Nadroparin Calcium in Patients with Subarachnoid Hemorrhage

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Nadroparin Calcium
    The Netherlands

  • Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Milrinone
    • Glucose Monohydrate
    France

  • Study on Levosimendan for Treating Aneurysmal Subarachnoid Hemorrhage in Intensive Care Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Levosimendan
    France

  • Study on Stereotactic Cisternal Lavage Therapy for Patients with Aneurysmal Subarachnoid Hemorrhage Using Urokinase, Nimodipine, and a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nimodipine
    • Urokinase
    • Calcium Chloride Dihydrate
    Germany

  • Ticagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Ticagrelor
    France
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!